Zynex Medical develops and provides non-invasive medical devices for pain management and muscle rehabilitation.  The self-described leading provider offers a range of products including TENS/IFC/NMES devices and braces for various body parts.

Zynex Medical

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Analytics

DNSSEC

Content Delivery Network

Business Management

Anna Lucsok

Chief Financial Officer

Dan Moorhead

Founder - Owner - CEO - Pilot

Kyle Doss

Owner/Cake Decorator

Lori Strickland

Owner

Orlando Johnson

Thomas Sandgaard

Vice President of Sales

Stephen Fox

Regional Sales Manager, Mid-Atlantic (DC, VA, MD, DE, WV, KY)

Alex Granger

Operations

Angela Singletary

Director of Human Resources

Dave Anttila

Josh Disbrow

Owner, President, and Chief Executive Officer

Chelle Van Burkleo

Barry Michaels

Board Member, Audit Committee Chair

Mike Mulry

Territory Manager

Health Care Companies With More Than 500 Employees (Top 10K)

Greater Denver Area Companies With Less Than $1B in Revenue (Top 10K)

Health Care Companies With Fewer Than 1000 Employees (Top 10K)

United States Companies With More Than $1M in Revenue (Top 10K)

Zynex engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries. Zynex Medical is a provider of electrotherapy products for home use, Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals and Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets. Zynex Medical's product line is fully developed, FDA-cleared, commercially sold, and has been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain.

Post-IPO Debt - Zynex

Post-IPO Equity - Zynex

Englewood

Colorado

United States

North America

Zynex

ZYNEX CEO Thomas Sandgaard Sells 6,000 Shares

Zynex Obtains FDA clearance for new Pain Management Device

Why Zynex Plunged Today

All You Need to Know About Zynex Rating Upgrade to Buy

Zynex Executives Recognized Among Top 25 in Medical Technology

Zynex GAAP EPS of $0.00 misses by $0.03, revenue of $46.53M misses by $1.16M

FDA Clears Zynex's Next-Generation NMES Device

Zynex GAAP EPS of $0.04 misses by $0.13, revenue of $47.28M misses by $8.34M

Zynex Introduces New Products

Zynex Receives FDA Clearance for its Next Generation NMES Device

India

Asia

Philippines

Morocco

Africa

United Kingdom

Europe

HTML5

Amazon EC2

GoDaddy Premium DNS

Google Maps API

Wordpress

Microsoft Outlook

Google Fonts

Cloudflare CDN

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Zynex, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 21, 2024 9:03 AM	9c3e79e6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 21, 2024 9:03 AM	fbe53572
crunchbase trigger	general	Nov 22, 2024 7:44 AM	accac4bf
crunchbase profile	general	Nov 22, 2024 9:02 AM	6365eae9
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 1:57 PM	a992c915
peers	general	Oct 21, 2024 9:03 AM	17b5a521
news basic	general	Oct 21, 2024 9:03 AM	a67a9668
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ZYNEX

Zynex Medical

Last Close

8.11

22/11 21:00

Market Cap

285.34M

Beta: -

Volume Today

63.59K

Avg: -